Evidence of therapeutic options for the Cryopyrin-associated Periodic Syndrome: results from a scoping review of anti-IL-1 drugs on dermatological diseases
- Francisco Gómez-García,
- Juan L. Sanz-Cabanillas,
- Isabel Viguera-Guerra,
- Jesús Gay-Mimbrera,
- Beatriz Isla-Tejera,
- Macarena Aguilar-Luque,
- Juan Ruano
Francisco Gómez-García
Immune-mediated Inflammatory Skin Disease research group, IMIBIC/Reina Sofía University Hospital/University of Córdoba, Menendez Pidal Ave, 14004 Córdoba, Spain, Department of Dermatology, Reina Sofía University Hospital, Menendez Pidal Ave, 14004 Córdoba, Spain
Author ProfileJuan L. Sanz-Cabanillas
Immune-mediated Inflammatory Skin Disease research group, IMIBIC/Reina Sofía University Hospital/University of Córdoba, Menendez Pidal Ave, 14004 Córdoba, Spain
Author ProfileIsabel Viguera-Guerra
Agencia de Evaluación de Tecnologías Sanitarias (AETSA), Consejería de Salud, Junta de Andalucía, 41020 Sevilla, Spain.
Author ProfileJesús Gay-Mimbrera
Immune-mediated Inflammatory Skin Disease research group, IMIBIC/Reina Sofía University Hospital/University of Córdoba, Menendez Pidal Ave, 14004 Córdoba, Spain
Author ProfileBeatriz Isla-Tejera
Department of Pharmacy, Reina Sofía University Hospital, Menendez Pidal Ave, 14004 Córdoba, Spain
Author ProfileMacarena Aguilar-Luque
Immune-mediated Inflammatory Skin Disease research group, IMIBIC/Reina Sofía University Hospital/University of Córdoba, Menendez Pidal Ave, 14004 Córdoba, Spain
Author ProfileJuan Ruano
Department of Dermatology, Reina Sofía University Hospital, Menendez Pidal Ave, 14004 Córdoba, Spain
Corresponding Author:[email protected]
Author Profile
